Literature DB >> 30156164

Taxane Induced Cystoid Macular Edema: Case Report and Integrated Pathogenic Theory.

M Kanakis1, I Georgalas2, T Makatsoris3, N Pharmakakis1.   

Abstract

PURPOSE: To report a case of a 73-year-old man who presented with decreased visual acuity due to bilateral macular edema after paclitaxel administration for prostate cancer.
METHODS: The ophthalmic evaluation consisted of medical and ocular history, Best Corrected Visual Acuity, slit-lamp biomicroscopy and Spectral-domain optical coherence tomography / Fluorescein Angiography.
RESULTS: Optical Coherence Tomography and Fluorescein Angiography revealed silent cystoid macular edema. After consulting with the oncologist, the cessation of paclitaxel therapy was decided. The patient presented a gradual but steady resumption of the retinal edema, with complete restoration of normal retinal morphology and function within two months. The pathogenesis of the silent Cystoid Macular Edema (CME) is still unclear. Based on our case and a critical review of the previous observations and published data, we propose that the underlying cause of Taxane induced CME is the functional failure of Aquaporin mediated water transport at the level of retinal Intermediate and Deep capillary plexuses, and at lesser extent at the level of the Retinal Pigment Epithelium.
CONCLUSION: Taxane induced silent CME should be attributed to the action of Taxanes on the microtubule guided aquaporin vesicles transport to the cell membrane. In our case of Taxane induced silent CME, withdrawal of the taxane was enough for complete recovery, and no additional treatment was needed. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Cystoid macular edema; angiographically silent macular edema; aquaporins; integrated pathogeniczzm321990theory; paclitaxel; taxanes.

Mesh:

Substances:

Year:  2019        PMID: 30156164     DOI: 10.2174/1574886313666180828163016

Source DB:  PubMed          Journal:  Curr Drug Saf        ISSN: 1574-8863


  4 in total

1.  Risk of Ocular Adverse Events With Taxane-Based Chemotherapy.

Authors:  Mohit Sodhi; Sonia N Yeung; David Maberley; Frederick Mikelberg; Mahyar Etminan
Journal:  JAMA Ophthalmol       Date:  2022-09-01       Impact factor: 8.253

Review 2.  Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges.

Authors:  Horace Massa; Spyros Y Pipis; Georgios D Panos; Temilade Adewoyin; Athanasios Vergados; Sudeshna Patra
Journal:  Clin Ophthalmol       Date:  2019-09-10

3.  Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients.

Authors:  Paula Montero; Martín Pérez-Leal; Jose Alejandro Pérez-Fidalgo; Celia Sanz; Cristina Estornut; Inés Roger; Javier Milara; Andrés Cervantes; Julio Cortijo
Journal:  Cancers (Basel)       Date:  2022-02-23       Impact factor: 6.639

4.  Regression of taxane-related cystoid macular edema after topical dorzolamide treatment: two case reports.

Authors:  Mitsuru Otsubo; Reiko Kinouchi; Takayuki Kamiya; Akitoshi Yoshida
Journal:  J Med Case Rep       Date:  2021-07-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.